Gene Query: DDX42

Dataset Description Geneva Score
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 126.26
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 29.92
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 29.87
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 26.88
CD95/Fas ligand mRNA is toxic to cells 24.94
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 22.02
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 20.34
Gene expression changes caused by KRAS in MCF-10A 19.66
The interplay between SOX4 and SMAD3 in the context of breast cancer 18.37
Regulation of highly expressed hCINAP on translatome 18.16
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 17.36
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 16.92
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 16.92
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 16.04
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 15.45
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 15.43
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 15.41
Survival of pancreatic cancer cells lacking KRAS function 15.39
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 14.78
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 14.6
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 14.54
RIG-I and MDA5 fRIP during KSHV lytic reactivation 14.52
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 14.15
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 13.69
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 13.69
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 13.38
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 13.15
3’ Uridylation Expands miRNA Target Repertoire 12.98
RNA-seq of naive and primed ES cells 12.94
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 12.79
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.56
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 12.33
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 12.33
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 12.26
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 11.96
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 11.51
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 11.39
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 11.09
RNA-sequencing in irradiated and normal A549 cells. 10.97
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 10.89
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 10.88
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 10.82
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 10.53
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 10.53
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 10.48
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.42
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 10.4
Global Mapping of Human RNA-RNA Interactions 10.23
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.18
RNA-seq of YB5 cells treated with Proscillaridin A 10.16
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 9.86
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.84
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 9.82
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 9.8
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 9.8
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 9.68
Genes significantly down or Up-regulated upon RNF219 knockdown 9.61
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 9.61
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 9.61
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 9.56
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 9.54
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 9.42
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 9.37
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.36
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 9.17
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.14
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 9.11
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 9.07
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 9.02
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 8.87
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 8.81
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 8.77
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 8.71
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 8.62
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 8.46
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.44
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.44
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 8.42
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 8.42
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.39
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.37
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 8.36
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 8.34
Landscape and variation of RNA secondary structure across the human transcriptome 8.32
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 8.19
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 8.19
High-throughput sequencing of pluripotent cells 8.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.17
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 8.1
RNA sequencing of primary human platelets and in vitro cell lines 8.09
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 8.05
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.01
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 8.0
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.98
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 7.89
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.79
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 7.75
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.74
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.69
MYC dependent mRNA translation shapes gene expression and cell biology 7.66
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 7.65
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 7.6
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 7.51
T47D RNA-seq and ChrRNA-seq data 7.49
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.49
RNA transcriptome analysis during HSV-1 infection 7.46
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.45
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 7.45
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.38
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.38
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 7.35
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 7.35
Paxillin regulates genomic networks in prostate cancer [PC3] 7.33
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 7.31
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 7.31
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 7.3
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 7.3
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.29
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 7.24
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 7.21
DRB/GRO-Seq -/+ UV 7.15
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.12
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.11
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 7.03
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 7.02
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.99
STRIPAK directs PP2A activity to promote oncogenic transformation 6.94
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.93
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 6.83
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 6.81
MeRIP-seq for heat shock in B-cell lymphoma cells 6.78
DART-seq: an antibody-free method for global m6A detection 6.78
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.78
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.68
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.68
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 6.68
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.68
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 6.64
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.61
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.61
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 6.51
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.5
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.45
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 6.45
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 6.45
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.42
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.42
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 6.39
Molecular Criteria for Defining the Naive Human Pluripotent State 6.31
TCF7L1 knockdown in pancreatic cancer 6.25
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 6.25
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.21
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.21
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.2
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 6.2
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 6.2
R430: A potent inbibitor of DNA and RNA viruses 6.16
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.16
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.15
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.14
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.09
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.08
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 6.0
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 5.99
Lipid degradation promotes prostate cancer cell survival 5.99
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 5.96
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 5.96
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 5.94
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 5.92
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 5.92
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.91
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.9
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.9
Identification of Atrial Fibrillation associated genes and functional non-coding variants 5.88
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.86
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 5.84
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.8
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.8
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 5.79
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.77
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 5.71
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 5.71
SLIGRL-induced gene expression changes in NHEK cells 5.7
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 5.68
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.68
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.68
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 5.63
Transcriptomic analysis of the HOTAIR-regulated genes 5.62
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.59
Differetially expressed genes after hTR overexpression in U2OS cells 5.57
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 5.55
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.49
METTL3 and WTAP 5.45
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.44
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 5.41
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 5.41
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 5.4
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 5.4
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.39
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.35
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 5.34
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.33
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.31
RNA m5C Methylation in breast cancer using MeRIP-Seq 5.27
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.26
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 5.21
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.21
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 5.19
Seletive inhibition of CDK9 in DLBCL cell lines 5.18
A transcriptome dataset revealing the molecular features of breast cancer stem cells 5.17
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 5.09
snRNAs as regulators of alternative splicing 5.04
Human HAP1 cells before and after nutrient deprivation 5.04
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.04
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 5.03
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.01
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 4.98
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.98
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.96
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.95
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.92
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.89
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 4.85
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.8
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 4.78
RNA-seq of RKO cells with cTAZ KO or putback 4.77
Capturing the Interactome of Newly Transcribed RNA 4.76
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.76
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.75
4sU-seq of HFF exposed to salt and heat stress 4.75
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 4.72
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.7
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 4.69
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.65
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 4.64
Expression profiling of MCF-7 cells with treatment of TCDD 4.64
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 4.63
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 4.63
X-Ray induced DNA-Hydroxymethylation changes 4.61
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 4.53
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.53
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.5
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 4.47
Transcriptome wide analysis of classically and alternatively activated macrophages 4.42
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 4.4
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 4.39
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 4.38
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 4.29
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.28
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.27
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.27
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 4.23
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 4.22
LIN28A Over-expression RNAseq 4.21
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 4.21
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 4.16
CDK12 mediated transcriptional regulation in U2OS cells 4.15
Global response to chemotherapy-induced apoptosis 4.14
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.1
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 4.07
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.0
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.96
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 3.95
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.92
mRNA expression in human DAOY cells 3.91
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.91
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.89
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.89
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.87
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 3.83
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 3.81
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.76
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.7
Determination of tRNA aminoacylation levels by high throughput sequencing 3.68
Tpl-2 small molecule project 3.67
Tpl-2 and MEK small molecule inhibitors 3.67
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.65
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.61
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.58
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.57
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.55
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.51
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.5
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.5
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 3.5
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.49
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.47
Cajal bodies are linked to genome conformation [RNA-Seq] 3.46
Cajal bodies are linked to genome conformation 3.46
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 3.42
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.39
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 3.39
Transcriptome analysis of peripheral blood monocytes 3.38
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.31
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 3.29
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 3.28
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.26
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.25
The transcriptome and chromatin accessbility landscape of mammalian germline 3.25
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.22
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 3.22
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.19
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.19
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 3.12
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.09
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.06
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.06
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.06
Metabolism as an early predictor of DPSCs aging 2.93
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.88
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.87
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.86
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.81
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.79
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 2.79
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.78
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.73
Gene expression analysis in response to hypoxic pathway inhibition 2.67
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.64
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 2.64
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.62
miR-93 Targets in Human Endothelial Cells 2.62
Ribosome profiling upon inhibition of eIF4A 2.61
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.58
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 2.56
Comparative Analysis of Cas9 Activators Across Multiple Species 2.52
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.5
RNA Sequencing of Human iPS derived Cardiomyocytes 2.49
The bromodomain protein BRD4 regulates splicing during heat shock 2.48
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.48
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.48
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.46
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.44
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 2.43
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.39
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 2.35
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 2.35
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 2.35
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.3
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.29
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.29
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 2.28
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.2
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.17
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 2.17
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 2.17
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.12
Real-time observation of light-controlled transcription in living cells 2.07
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.07
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.07
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.07
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.06
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.04
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 2.03
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.03
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.0
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.96
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.91
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.86
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 1.86
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 1.86
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.85
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.84
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.84
In vitro modeling of human germ cell development using pluripotent stem cells 1.8
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.8
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.8
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 1.76
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.75
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.75
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.74
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 1.73
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.72
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.71
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.67
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.67
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.66
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.62
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.6
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.59
Transcriptomic profiling of human peripheral blood-derived mast cells 1.59
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.58
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.57
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.57
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.55
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.53
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.51
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.51
High-resolution comparative analysis of great ape genomes 1.49
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.48
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.46
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.41
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.39
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.38
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.38
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.36
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.35
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.33
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.33
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.32
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.31
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.3
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.26
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.25
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.23
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.23
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.21
Modulation of nonsense-mediated decay by rapamycin 1.21
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.19
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.18
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.18
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.18
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.15
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.14
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.14
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.08
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.04
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.03
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.02
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.02
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 1.02
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.01
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.01
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.0
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.99
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.99
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.99
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.95
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.95
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.94
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 0.93
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.9
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.89
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.89
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.88
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.88
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.81
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.81
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.78
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.77
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.76
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.7
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.69
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.61
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.59
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.57
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.57
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.57
Myc activation coordinates gene transcription and protein translation responses 0.54
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.54
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.52
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.48
Hepatic transcriptome of pediatric hepatoblastoma. 0.48
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.46
Enhancer activation during EGF response 0.45
K562 polyA RNA-Seq 0.44
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.43
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.42
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.4
Expression analysis of the TAF1 syndrome 0.4
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.4
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.4
Effect of ILF3 on translation during homeostasis and the antiviral response 0.38
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.36
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.36
The pioneer factor CEBPA modulates vitamin D signaling 0.35
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.35
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.34
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.34
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.34
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.34
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.33
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.31
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.3
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.29
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.28
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.26
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.21
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.2
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.18
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.14
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.14
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.12
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.11
Aging-associated patterns in the expression of human endogenous retroviruses 0.09
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.09
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.08
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.07
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.07
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.06
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.06
Gene expression alterations of pancreatic intraepithlial neoplasia 0.02
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.01
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation